Fast rule lookup with arbitrary IP range configurations
    31.
    发明申请
    Fast rule lookup with arbitrary IP range configurations 审中-公开
    使用任意IP范围配置进行快速查找

    公开(公告)号:US20050154762A1

    公开(公告)日:2005-07-14

    申请号:US10757801

    申请日:2004-01-14

    申请人: Bing Wang

    发明人: Bing Wang

    摘要: Enabling a relatively fast look up for a rule associated with an arbitrarily selectable IP address. In one embodiment, RSBound objects are sorted into an array where each RSBound object is composed of a bound IP address (BIP), sister BIP, type, index, sister index, and a configured rule. The BIPs are derived from arbitrary user-specified IP addresses or IP address ranges. Each single IP address configuration derives one RSBound entry, where the BIP is the given IP address itself; and each IP range configuration derives two RSBound entries, and the range's lower bound and upper bound are their respective BIPs. The array is sorted primarily based on the RSBound's BIP value, and their type and pair information are the tiebreakers. If a configured rule needs to be searched for a given IP address, a binary search is performed first to find a starting entry, from where a jump-skip search is performed to find the best matching rule for the given IP address. Additionally, although this invention is well suited for IP range matching, it can also be used to match keys with arbitrary ranges of other non-IP address types, e.g., mobile telephone numbers.

    摘要翻译: 启用相对较快的查找与任意选择的IP地址相关联的规则。 在一个实施例中,RSBound对象被排序到阵列,其中每个RSBound对象由绑定的IP地址(BIP),姊妹BIP,类型,索引,姊妹索引和配置的规则组成。 BIP源自任意用户指定的IP地址或IP地址范围。 每个单个IP地址配置导出一个RSBound条目,其中BIP是给定的IP地址本身; 并且每个IP范围配置导出两个RSBound条目,范围的下限和上限是它们各自的BIP。 该阵列主要根据RSBound的BIP值进行排序,它们的类型和配对信息是打破者。 如果需要为给定的IP地址搜索配置的规则,则首先执行二叉搜索以找到起始条目,从那里执行跳跃跳过搜索以找到给定IP地址的最佳匹配规则。 另外,尽管本发明非常适用于IP范围匹配,但也可以将密钥与其他非IP地址类型(例如,移动电话号码)的任意范围进行匹配。

    Low-temperature press process for making insulating glass assemblies
    34.
    发明申请
    Low-temperature press process for making insulating glass assemblies 有权
    制造绝缘玻璃组件的低温压制工艺

    公开(公告)号:US20050003117A1

    公开(公告)日:2005-01-06

    申请号:US10798590

    申请日:2004-03-11

    CPC分类号: C03C27/10 Y02A30/25 Y02B80/24

    摘要: A process for making an insulating glass assembly is disclosed, the process including applying a sealant composition to a surface of a spacer; contacting the sealant composition with a glass pane, and applying pressure on the glass pane to bond the glass pane to the spacer through the sealant composition, the pressure being applied at an ambient temperature of from about 15° C. to about 60° C.

    摘要翻译: 公开了制造绝缘玻璃组件的方法,该方法包括将密封剂组合物施加到间隔物的表面上; 使密封剂组合物与玻璃板接触,并在玻璃板上施加压力以通过密封剂组合物将玻璃板粘合到间隔件上,该压力在约15℃至约60℃的环境温度下施加。

    Cytoprotective benzofuran derivatives
    35.
    发明授权
    Cytoprotective benzofuran derivatives 失效
    细胞保护性苯并呋喃衍生物

    公开(公告)号:US06653346B1

    公开(公告)日:2003-11-25

    申请号:US10361141

    申请日:2003-02-06

    申请人: Bing Wang Jian Chen

    发明人: Bing Wang Jian Chen

    IPC分类号: A61K3134

    摘要: Cytoprotective compounds, many of which are benzofuran derivatives are useful in the treatment of certain ischemic or inflammatory conditions, including but not limited to stroke, myocardial infarction, congestive heart failure, and skin disorders characterized by inflammation or oxidative damage. They are also useful in the manufacture of pharmaceutical and cosmetic formulations for the treatment of such conditions.

    摘要翻译: 其中许多是苯并呋喃衍生物的细胞保护化合物可用于治疗某些缺血性或炎症性疾病,包括但不限于中风,心肌梗死,充血性心力衰竭和以炎症或氧化损伤为特征的皮肤病症。 它们也可用于制备用于治疗这些病症的药物和化妆品制剂。

    High refractive-index hybrid material prepared by titanium alkoxide and
a phosphine containing oligomer
    37.
    发明授权
    High refractive-index hybrid material prepared by titanium alkoxide and a phosphine containing oligomer 失效
    由钛醇盐和含膦低聚物制备的高折射率杂化材料

    公开(公告)号:US5143988A

    公开(公告)日:1992-09-01

    申请号:US552634

    申请日:1990-07-13

    摘要: New hybrid materials have been prepared by combining a titanium alkoxide sol with high a refractive index phosphine oxide-containing oligomeric component (triethoylsilane-capped poly(arylene ether phosphine oxide). These materials are prepared by the sol-gel method. The final products are transparent and display high refractive index (n.sub.D =1.66-1.80). The refractive index of these hybrid materials display a linear relationship with titanium oxide content.

    摘要翻译: 通过将烷氧基钛溶胶与高折射率含氧化膦的低聚成分(三丁基硅烷封端的聚(亚芳基醚氧化膦))结合制备新的杂化材料,这些材料通过溶胶 - 凝胶法制备,最终产物为 透明度高,折射率高(nD = 1.66〜1.80),折射率与氧化钛含量呈线性关系。

    Processes of synthesizing dihydropyridophthalazinone derivatives
    38.
    发明授权
    Processes of synthesizing dihydropyridophthalazinone derivatives 有权
    合成二氢吡啶并酞嗪酮衍生物的方法

    公开(公告)号:US08765945B2

    公开(公告)日:2014-07-01

    申请号:US13023140

    申请日:2011-02-08

    IPC分类号: C07D237/36

    摘要: Provided herein are processes for synthesizing dihydropyridophthalazinone derivatives, such as for example, 5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one and its stereoisomers, which are potent poly(ADP-ribose)polymerase (PARP) inhibitors as well as novel synthetic intermediate compounds.

    摘要翻译: 本文提供了合成二氢吡啶并二氮杂萘酮衍生物的方法,例如5-氟-8-(4-氟苯基)-9-(1-甲基-1H-1,2,4-三唑-5-基) 9-二氢-2H-吡啶并[4,3,2-de]酞嗪-3(7H) - 酮及其立体异构体,它们是有效的聚(ADP-核糖)聚合酶(PARP)抑制剂以及新的合成中间体化合物。

    Crystalline (8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one tosylate salt
    39.
    发明授权
    Crystalline (8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one tosylate salt 有权
    结晶(8S,9R)-5-氟-8-(4-氟苯基)-9-(1-甲基-1H-1,2,4-三唑-5-基)-8,9-二氢-2H-吡啶 [4,3,2-de]酞嗪-3(7H) - 酮甲苯磺酸盐

    公开(公告)号:US08735392B2

    公开(公告)日:2014-05-27

    申请号:US13277607

    申请日:2011-10-20

    IPC分类号: A01N43/58 A61K31/495

    CPC分类号: C07D471/06

    摘要: Provided herein are (8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one tosylate salt forms, including crystalline forms, and methods of their preparation. Pharmaceutical compositions comprising a (8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one tosylate salt are also provided, as are methods of using (8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one tosylate salt to treat a disease or condition, such as a cancer.

    摘要翻译: 本文提供的是(8S,9R)-5-氟-8-(4-氟苯基)-9-(1-甲基-1H-1,2,4-三唑-5-基)-8,9-二氢-2H- - 吡啶并[4,3,2-de]酞嗪-3(7H) - 酮甲磺酸盐形式,包括晶型,及其制备方法。 包含(8S,9R)-5-氟-8-(4-氟苯基)-9-(1-甲基-1H-1,2,4-三唑-5-基)-8,9-二氢 - 还提供了使用(8S,9R)-5-氟-8-(4-氟苯基)-9(7H) - 酮的方法,使用2-吡啶并[4,3,2- - (1-甲基-1H-1,2,4-三唑-5-基)-8,9-二氢-2H-吡啶并[4,3,2-de]酞嗪-3(7H) - 酮甲苯磺酸盐 治疗疾病或病症,如癌症。